Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
"Little Lanterns" Brighten Up the Path to Wealthiness with the Support from State Grid Wuwei Power Supply Company
-
Dynasty Wins One Silver and One Bronze Medals at 2024 HKIWSC
-
Baxter Reports Third-Quarter 2024 Results
-
Ubiquiti Inc. Reports First Quarter Fiscal 2025 Financial Results
-
Centana Growth Partners Acquires Majority Stake in Hippo’s First Connect Insurance Services
-
NRG Energy, Inc. Reports Third Quarter Results, Initiates 2025 Guidance, and Introduces Adjusted Net Income and Adjusted EPS
-
MEET ROMER AT STROLLERIA - NOVEMBER 9TH
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 07 11 2024] - (CGWL)
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Aton Announces Corporate and Operations Update
-
Invesco Ltd: Form 8.3 - DS Smith PLC; Public dealing disclosure
-
PNC Bank to Double Planned Branch Openings to More Than 200 Across Six States
-
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results
-
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
-
U-Haul Acquires 5 Self-Storage Properties in Northern Minnesota
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Ukrainian City of Vinnytsia Welcomes International Partners to Modernize its Infrastructure, and Partners With Earlybird Global and SRDB Law Firm.
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Sherwood Lumber Now a Distributer of RDI Railing
-
Velocity One Signs Merger Agreement With EMCORE (EMKR)
-
NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
-
Honey Badger Announces Change of Transfer Agent
-
Bedford Park Opportunities Fund Wins First Place at the 2024 Canadian Hedge Fund Awards with a return of 73.6%
-
Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies
-
Prospect Capital Announces Financial Results for Fiscal September 2024 Quarter
-
Neptune Software to Participate in 2024 ASUG TechConnect Event
-
NuVista Energy Ltd. Announces Strong Third Quarter 2024 Financial and Operating Results, LNG Agreement, 2025 Budget, and Enhanced Shareholder Return Strategy
-
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
-
Nexans to sell AmerCable to Mattr
-
Calumet Reports Third Quarter 2024 Results
-
Onex Reports Third Quarter 2024 Results
-
Main Street Duncan Gearing Up for Annual Holiday Stroll on November 16th
-
Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results
-
Novel Microdevices, Inc. Announces ~$2.7M Follow on Funding from NIH RADx® Tech
-
HORIZON PETROLEUM ANNOUNCES CONDITIONAL APPROVAL FOR REINSTATEMENT ONTO THE TSX VENTURE EXCHANGE AND CLOSING OF THE SECOND TRANCHE OF FINANCING
-
Seer to Participate in Upcoming November Investor Conferences
-
MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS
-
2nd Annual 2025 KEDO Nations Cup to Kick Off in Charlotte, NC, Raising Funds for Health Clinic in Liberia
-
Samsung Biologics earns ISO certifications in recognition of business excellence
-
Jensen Hughes Appoints Dominic Casserley as Executive Chair of the Board of Directors
-
Ultralife Corporation Reports Third Quarter Results
-
FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2024 RESULTS
-
TEXAS HUMANE LEGISLATION NETWORK HONORS FARMHOUSE FRESH SKINCARE AS 2024 HUMANE HERO AWARD RECIPIENT
-
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma
-
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
-
Bloomin’ Brands Announces 2024 Q3 Financial Results
-
Velocity One Signs Merger Agreement with EMCORE (EMKR)
-
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M17D1 in Advanced Solid Tumors
-
Xeris Biopharma Reports Third Quarter 2024 Financial Results
-
United Homes Group, Inc. Reports 2024 Third Quarter Results
